Amylyx Pharmaceuticals, Inc. (AMLX)

12.35 +0.14 (+1.15%) USD  |  NASDAQ  |  Jan 12, 11:29
More

Amylyx Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for AMLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Treace Medical Concepts, Inc. Upgrade
Baxter International, Inc. Upgrade
Humana, Inc. Upgrade
Avantor, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade